Marketed in 46 countries across Europe, the Americas, Asia, and parts of Africa, Fucidin is a globally distributed brand of fusidic acid, classified among antibiotics and chemotherapeutics for dermatological use. The page you are reading is intended for travellers, expatriates, and family members trying to identify whether Fucidin or an equivalent product is available in another country.
Fusidic acid is used in the management of bacterial skin and soft-tissue conditions, including impetigo, folliculitis, paronychia, infected dermatitis and contact dermatitis, and infected abrasions. The molecule is also used in ophthalmological preparations in several markets. Its mode of action is bacteriostatic, and it is positioned as a local antibacterial rather than a systemic one. The structured indication list further down this page sets out the registered uses recognised by national regulators in the markets where Fucidin is sold.
Because Fucidin has a broad international footprint, travellers frequently encounter the brand abroad — although the exact formulation, packaging, and prescription status differ from country to country. Markets where Fucidin is registered include Canada, Denmark, Egypt, Australia, and Hong Kong, alongside many European and Asian jurisdictions. In some countries the same active ingredient is also sold as a generic or under a different brand name, particularly in topical and ophthalmic forms.
Other topical antibacterials used in similar dermatological indications are available worldwide, although they belong to distinct molecular families and are not interchangeable without clinical guidance. A pharmacist in the destination country can usually confirm whether a fusidic acid product is on the local formulary and under what name. Anyone using Fucidin, considering it, or looking for a regional equivalent should treat that decision as one to take with a qualified healthcare provider.
